Your browser doesn't support javascript.
loading
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis.
Bonneau, Claire; Paintaud, Gilles; Trédan, Olivier; Dubot, Coraline; Desvignes, Céline; Dieras, Véronique; Taillibert, Sophie; Tresca, Patricia; Turbiez, Isabelle; Li, Jacques; Passot, Christophe; Mefti, Fawzia; Mouret-Fourme, Emmanuelle; Le Rhun, Emilie; Gutierrez, Maya.
Afiliação
  • Bonneau C; Department of Surgery, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France.
  • Paintaud G; Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Tours, France.
  • Trédan O; Department of Oncology, Centre Leon Berard, 28 Prom. Léa et Napoléon Bullukian, 69008, Lyon, France.
  • Dubot C; Department of Oncology, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France.
  • Desvignes C; Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Tours, France.
  • Dieras V; Department of Oncology, Institut Curie, Hôpital Claudius Regaud, 26 Rue d'Ulm, 75005, Paris, France.
  • Taillibert S; Department of Neurology Mazarin, Groupe Hospitalier Pitié Salpétrière, 47 bd del'hôpital, 75013, Paris, France; Assistance Publique des Hôpitaux de Paris, Paris, France; Université Pierre et Marie Curie, Paris VI, Paris, France.
  • Tresca P; Department of Clinical Research, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France.
  • Turbiez I; Department of Clinical Research, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France.
  • Li J; Department of Epidemiology, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.
  • Passot C; Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Tours, France.
  • Mefti F; Department of Oncology, Clinique de La Porte Verte, 6 Avenue Maréchal Franchet D'Esperey, 78004, Versailles, France.
  • Mouret-Fourme E; Department of Epidemiology, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.
  • Le Rhun E; Lille University, Inserm U1192 PRISM, Villeneuve d'Ascq, France; Breast unit, Department of Medical Oncology, Oscar Lambret Center, 3 Rue Frédéric Combemale, 59000, Lille, France; Neuro-oncology, Department of Neurosurgery, University Hospital, Lille, France.
  • Gutierrez M; Department of Oncology, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. Electronic address: maya.gutierrez@curie.fr.
Eur J Cancer ; 95: 75-84, 2018 05.
Article em En | MEDLINE | ID: mdl-29635147
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinomatose Meníngea / Trastuzumab Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinomatose Meníngea / Trastuzumab Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França